[Calixar] Multidrug resistance ABC transporter ATP-binding/permease protein BmrA

[Calixar] Multidrug resistance ABC transporter ATP-binding/permease protein BmrA

Target name: Multidrug resistance ABC transporter ATP-binding/permease protein BmrA

Gene: bmrA

Uniprot Accession: O06967

Origin: Bacillus subtilis (strain 168)

Class: Multidrug resistance ABC transporter

Sequence: Full-length, wildtype sequence, with a N-terminus 6xHis-tag.

Affinity Tag​: His-tag (N-terminal)

Catalogue number: PP3

Theor. MW: 64.5 kDa​

Shipment temperature: Dry Ice

Storage conditions: Store at -80°C​

Expression system: Escherichia coli (BL21C43)

Purity: >90%

Purification: Immobilized Metal Affinity Chromatography

Activity: Confirmed by ATPase activity assay

Concentration​: Up to 5mg/ml

Sample buffer: 50mM Tris-Cl pH 8.0, 100 mM NaCl, 0.01% DDM, 10%glycerol

Available quantity: From 10µg up to mg scale

CALIXAR’s BmrA membrane protein (Multidrug resistance ABC transporter ATP-binding/permease protein BmrA) is an efflux protein and ABC transporter that acts as a mechanical pump for ATP dependent drug efflux. This unique characteristic makes BmrA membrane protein a powerful therapeutic target for multi-drug resistance studies.CALIXAR’s BmrA membrane targets aid in the exploration, improvement, validation of novel molecules and therapeutic antibodies. Our Multidrug resistance ABC transporter ATP-binding/permease protein BmrA is excellent for therapeutic indications such as bacterial resistance to antibiotics.Multidrug resistance ABC transporter ATP-binding/permease protein BmrA is a powerful therapeutic target for multi-drug resistance studies, ideal for therapeutic indications such as bacterial resistance to antibiotics.